Increased Mortality After Tuberculosis Treatment Completion in Persons Living With Human Immunodeficiency Virus in Latin America-Reference-Cited by-同舟云学术

Increased Mortality After Tuberculosis Treatment Completion in Persons Living With Human Immunodeficiency Virus in Latin America

Published:2019-10-20 Issue:1 Volume:71 Page:215-217
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Koenig Serena P¹²,Kim Ahra³,Shepherd Bryan E³,Cesar Carina⁴,Veloso Valdilea⁵,Cortes Claudia P⁶,Padgett Denis⁷,Crabtree-Ramírez Brenda⁸,Gotuzzo Eduardo⁹,McGowan Catherine C¹⁰,Sterling Timothy R¹⁰,Pape Jean W¹¹¹

Affiliation:

1. Le Groupe Haïtien d’Etude du Sarcome de Kaposi et des Infections Opportunistes, Port-au-Prince, Haiti

2. Division of Global Health Equity, Brigham and Women’s Hospital, Boston, Massachusetts, USA

3. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA

4. Fundación Huésped, Investigaciones Clínicas, Buenos Aires, Argentina

5. Instituto Nacional de Infectiologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil

6. Fundación Arriarán, University of Chile School of Medicine, Santiago, Chile

7. Instituto Hondureño de Seguridad Social and Hospital Escuela Universitario, Tegucigalpa, Honduras

8. Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Departmento de Infectología, Mexico City, Mexico

9. Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt, Lima, Peru

10. Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA

11. Center for Global Health, Weill Cornell Medicine, New York City, New York, USA

Abstract

Abstract We assessed the association between cured tuberculosis (TB) and mortality among persons living with human immunodeficiency virus (HIV) in Latin America. We compared survival among persons with and without TB at enrollment in HIV care, starting 9 months after clinic enrollment. In multivariable analysis, TB was associated with higher long-term mortality (hazard ratio, 1.57; 95% confidence interval, 1.25–1.99).

Funder

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciz1032/30246713/ciz1032.pdf

Reference12 articles.

1. Longevity loss among cured tuberculosis patients and the potential value of prevention;Hoger;Int J Tuberc Lung Dis,2014

2. Mortality after anti-tuberculosis treatment completion: results of long-term follow-up;Shuldiner;Int J Tuberc Lung Dis,2016